News

2022/01/18

Medivir’s MIV-818 obtains the International Nonproprietary Name fostroxacitabine bralpamide

Read more
2022/01/17

Jens Lindberg takes office as CEO of Medivir on January 24

Read more
2022/01/10

Medivir to present at the H.C. Wainwright BioConnect Virtual Conference

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.